Residual solvents in cannabis extracts

TL;DR

• Extraction with butane/propane (BHO) or CO2 requires complete post-purification ('purging').
• ICH Q3C(R8) classifies solvents by toxicity into 3 classes.
• Class-1 solvents (e.g. benzene) should be practically undetectable.
• GC-headspace analysis reliably detects residues at the ppm level.

Which solvents are used?

Butane hash oil (BHO) uses liquid butane or propane to extract terpenes and cannabinoids; supercritical CO2 is considered a 'cleaner' alternative since CO2 escapes residue-free at room pressure. Ethanol extraction is common for full-spectrum oils. Each process requires a post-purification step (vacuum oven, rotary evaporator) to remove solvent residue — incomplete 'purging' is the main cause of positive residue tests.

How are limits set?

The ICH Q3C(R8) guideline for pharmaceutical products serves as the reference for many cannabis labs, since there is no cannabis-specific Swiss standard. Class 1 solvents (carcinogenic/toxic, e.g. benzene) should be below the limit of detection; class 2 solvents (e.g. hexane, methanol) are tolerated up to specific PDE (permitted daily exposure) values; class 3 solvents (e.g. ethanol, acetone, isopropanol) are considered low in toxicity and permitted up to 5,000 ppm.

• Class 1: avoid (e.g. benzene, 1,1-dichloroethene)
• Class 2: limit (e.g. hexane, methanol, toluene)
• Class 3: low toxicity, up to 5000 ppm (e.g. ethanol, acetone, isopropanol)

Swiss regulatory framework and official responsibilities

The legal classification of solvent residues in Switzerland is heavily oriented towards the intended use of the end product. Since the amendment of the law in August 2022, doctors have been able to prescribe medical cannabis directly and without an exceptional permit from the Federal Office of Public Health (BAG). For these medical extracts, the strict quality specifications of Swissmedic and the Pharmacopoea Europaea apply. In contrast, CBD oils and over-the-counter hemp extracts fall under food or chemical law, the enforcement of which is the responsibility of the Federal Food Safety and Veterinary Office (BLV) and the cantonal laboratories. In practice, these differing responsibilities lead to varying levels of control intensity.

The cantonal enforcement authorities carry out random checks in retail to ensure compliance with the limit values for consumer products. Since the Swiss market for cannabis products is regulated by federal limit values of under one percent total THC for legal sale, the raw materials used for extraction must also be processed with precision. Producers are obliged to provide seamless proof of batch purity. Exceeding the tolerance values can lead to sales bans, expensive recalls, and in the worst case, criminal consequences, which is why Swiss manufacturers are increasingly relying on certified Swiss laboratories.

• Regulation of medical cannabis by Swissmedic in accordance with pharmacopoeia standards.
• Responsibility of the BLV for over-the-counter CBD extracts in the Swiss market.
• Cantonal random checks to verify consumer safety.
• Mandatory batch testing for domestic manufacturers and importers.

The purging process in practice

The technical removal of solvents, known as purging, requires precisely controlled physical processes in professional manufacturing. After the actual extraction, the raw material usually exists as a viscous mixture in which solvent molecules are physically trapped. By using specialized vacuum ovens, the boiling point of the solvents is drastically lowered, allowing them to evaporate even at low temperatures that protect the product. This step is critical, as excessively high temperatures would destroy the valuable, temperature-sensitive terpenes and cannabinoids or unintentionally decarboxylate the THC.

Another important purification step is winterization, in which the extract is dissolved in ethanol and cooled down significantly to precipitate plant waxes and fats. These lipids tend to trap solvents such as butane or propane and prevent complete degassing. After filtering out the waxes, the ethanol must in turn be completely removed using a rotary evaporator. Errors in this complex interplay of temperature, pressure, and time inevitably lead to measurable residues in the end product, highlighting the importance of validated process control.

• Vacuum drying for a material-friendly reduction of solvent boiling points.
• Winterization to remove waxes that could trap gases.
• Balance between effective degassing and the preservation of volatile terpenes.
• Risk of entrapment in extracts that are too viscous or cooled down too quickly.

Risks of incomplete purification for consumers

The health risks of solvent residues depend significantly on the type of solvent and the method of consumption. When vaporizing or dabbing extracts, remaining solvents are heated directly and inhaled deep into the lungs. This can lead to acute respiratory irritation, coughing, and headaches. In contrast to oral ingestion via the gastrointestinal tract, the inhaled gas enters the bloodstream directly without the protective first-pass effect of the liver, potentially increasing toxicity.

Chronic consumption of insufficiently purified products carries the risk of long-term organ damage, especially when using prohibited Class 1 solvents such as benzene, which are classified as carcinogenic. For consumers in Switzerland, it is therefore advisable to purchase exclusively laboratory-tested products with transparent certificates of analysis. In case of suspected acute poisoning from contaminated extracts, the national emergency number of Tox Info Suisse (145) provides a fast, professional point of contact for risk assessment and initiating immediate measures.

• Increased toxicity during inhalative consumption due to direct entry into the bloodstream.
• Acute respiratory irritation and headaches as typical warning signs.
• Long-term risks such as organ toxicity with regular consumption of contaminated oils.
• Tox Info Suisse (emergency number 145) as the central point of contact for symptoms of poisoning.

Analytical challenges and laboratory effort

The analytical determination of solvent residues presents laboratories with significant technical and economic challenges. Since cannabis extracts are highly complex mixtures of substances containing hundreds of terpenes and cannabinoids, these can interfere with the measurement signals in gas chromatography. Certain terpenes exhibit similar retention times to common solvents, which can lead to false-positive results without careful calibration and the use of mass spectrometers. The validation of measurement methods therefore requires highly qualified personnel and expensive reference substances.

For producers, comprehensive laboratory analysis represents a significant financial and time expenditure, which directly impacts the price for the end customer. A common mistake in practice is also inadequate sampling, where non-representative parts of a batch are tested. Since solvents can distribute unevenly in viscous extracts, a single sample often does not provide a reliable picture of the entire production. Swiss quality laboratories therefore require precise sampling protocols to guarantee the validity of the certificates.

• Complex cannabis matrix with terpenes complicates unambiguous signal assignment.
• Need for high-resolution mass spectrometry to avoid incorrect measurements.
• High financial expenditure for validation and regular calibration.
• Risk of inaccurate results due to uneven solvent distribution within the batch.

FAQ